LOS ANGELES, June 17 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Vicor Technologies, Inc. (OTC Bulletin Board: VCRT). Ross Silver, Principal Analyst of Vista Partners stated, "The completion of the MUSIC trial was a significant milestone in Vicor's history. Vicor intends to use the results of the MUSIC Trial, using the PD2i®, to support a 510(k) submission to the Food and Drug Administration (FDA) for additional marketing claims, which could result in significant revenue growth." To download a free copy of the report, please visit the Vista Partners website, www.vistap.com, and click on the download research icon.
About Vista Partners:
Vista Partners LLC was founded in 2005 and has offices in California and Oregon. We are one of the fastest growing independently owned equity research and consulting firms in the United States. Our professional staff has backgrounds in finance, corporate communications and investment banking. We have built a name for ourselves in the small cap space due to our selection of profitable investment recommendations.
SOURCE Vista Partners